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Abstract
Classic galactosemia is a rare inherited disorder of galactose metabolism. Primary ovarian insufficiency (POI) with subfertility
affects > 80% of female patients and is an important concern for patients and their parents. Healthcare providers are often
consulted for subfertility treatment possibilities. An option brought up by the families is intrafamilial oocyte donation (moth-
er-to-daughter or sister-to-sister). In addition to POI, galactosemia patients can also present varying cognitive and neurological
impairments, which may not be fully clear at the time when mother-to-daughter oocyte donation is considered. Ethical and
societal aspects arise when exploring this option. This study aimed to provide guidance in aspects to consider based on the views
of different groups involved in the oocyte donation process. A qualitative study using in-depth semi-structured interviews with
> 50 participants (patients, family members, and healthcare providers) was conducted. From these interviews, themes of concern
emerged, which are illustrated and reviewed: (1) family relations, (2) medical impact, (3) patients’ cognitive level, (4) agreements
to be made in advance and organization of counseling, (5) disclosure to the child, and (6) need for follow-up. We conclude that
discussing and carrying out intrafamilial oocyte donation in galactosemia patients requires carefully addressing these themes.
This study adds value to the already existing recommendations on intrafamilial oocyte donation in general, since it highlights
important additional aspects from the perspectives of patients and their families.
Introduction
Primary ovarian insufficiency (POI) with subfertility is an
important concern in classic galactosemia patients and their
families. With a prevalence of > 80% in female patients, POI
is the most common complication, representing the greatest
psychological burden for women with this disorder (Kaufman
et al. 1986; Bosch et al. 2004; Fridovich-Keil et al. 2011).
Classic galactosemia is a rare inherited disorder of galactose
metabolism caused by severe deficiency of the second step in
the main pathway for galactose catalyzed by galactose-1-
phosphate uridylyltransferase (GALT) (Coelho et al. 2017).
Although a galactose-restricted diet quickly relieves the initial
severe illness, diet-independent complications occur later in
life, including POI. Female patients present a wide phenotypic
spectrum of POI that can vary from primary amenorrhea to
normal pubertal development, but irregular or absent menstru-
al cycles at a later stage (Rubio-Gozalbo et al. 2010;
Fridovich-Keil et al. 2011). Although spontaneous pregnan-
cies occur despite the presence of POI (Gubbels et al. 2008;
van Erven et al. 2017), concerns about subfertility remain.
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Healthcare providers are frequently consulted for subfertility
treatment possibilities. An option that is often brought up by
families is intrafamilial oocyte donation, from mother to
daughter (intergenerational) or from sister to sister
(intragenerational). However, an important aspect in this dis-
order is a varying spectrum in cognitive impairments, includ-
ing intelligence quotient (IQ, 47–122), in addition to POI
(Waisbren et al. 2012; Welling et al. 2017). When mother-to-
daughter oocyte donation is considered, this cognitive impair-
ment may not yet be clear, in view of the young age of the
galactosemic daughter. Intrafamilial oocyte donation raises
ethical and societal questions, and professionals might be re-
luctant to mention this option. Several documents have recent-
ly been published on intrafamilial oocyte donation that ad-
dress some of the concerns raised by this procedure
(Nederlandse Vereniging voor Obstetrie en Gynaecologie,
NVOG 2016; Balkenende et al. 2017).
This study aimed to provide guidance in aspects to consider
when discussing this option in this specific group, based on
the views of different groups involved in the oocyte donation
process, including patients and their families.
Methods
Study design and selection of participants
This qualitative study was conducted in the Maastricht
University Medical Center+, the Netherlands. The aim of this
study was to evaluate the views and attitudes regarding ethical
and societal aspects of intrafamilial oocyte donation in women
with classic galactosemia. Possible participants were informed
about this study in person, at the outpatient’s clinic, or by
telephone when consent to be re-contacted was given in pre-
vious studies. When participants were interested, written in-
formation was sent. Patients (≥ 18 years of age), family mem-
bers, and healthcare providers with different specialties in-
volved in the treatment or follow-up of galactosemia patients
were solicited for this study. This allowed us to collect a wide
range of opinions, from different perspectives. Participants
were enrolled from January 2017 to March 2017.
Approval for this study from our Research Ethics
Committee was requested. After reviewing the study protocol,
the committee agreed that official review and approval of this
study was not necessary, due to the fact that it did not involve
medical information. Written informed consent was obtained
from all patients to participate in the study.
Questionnaire and data collection
In-depth interviews using a semi-structured questionnaire
were conducted, adjusted for the different groups (example
in the supplementary material [English version]). The first
author developed the questionnaire after examination of the
literature and day-to-day experience with patients and other
care providers, and discussed the questions with the other
authors. When consensus was reached, the final version was
drafted. Both close-ended and open questions were used to
ensure that the questions would capture the relevant themes
concerning intrafamilial oocyte donation. Through open-
ended questions, participants were free to explore their views
on different topics. Interviews with 14 patients, 19 family
members, and 34 professionals from four academic centers
in the Netherlands were conducted, between April 2017 and
July 2017 (the characteristics of the participants are available
in the supplementary material). All interviews were conducted
by the first two authors. Interviews lasted between 30 and
45 min and took place over telephone or in the working place
of the respondent. All interviews were audiotaped and tran-
scribed verbatim.When no new information was derived from
the interviews, saturation was reached, and participant enrol-
ment was stopped (Guest et al. 2006).
Data analysis
Data analysis was performed based on the constant compara-
tive method (Malterud 2001). Views from different groups
were collected and compared. The first two authors identified
the texts that reflected the relevant themes emerging from the
interviews. In consultation with the last author, the topics were
refined and further developed. To highlight the different
topics, representative quotations were identified.
Results
Intrafamilial oocyte donation comes with many delicate is-
sues. One of the interviewed professionals summarized it very
well: BI must admit this type of donation has some difficult
sides to it, but those are definitely not insurmountable.^
Six main themes to consider when discussing this option
were identified through these interviews: (1) family relations,
(2) medical impact, (3) patient’s cognitive level, (4) agree-
ments to be made in advance and organization of counseling,
(5) disclosure to the child, and (6) need for follow-up.
Theme 1: can intrafamilial oocyte donation put family
relations at risk?
Most family members and professionals express their concern
that overattachment of the donor to the offspring and different
opinions in raising the child could cause role conflicts, as
illustrated by the quotation below.
Donating oocytes can lead to a different view of the
child; you will get a grandchild and a child at the same
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time. For both parties, this would be a psychological
burden. You must be aware that despite they are your
oocytes; you are not really the child’s mother. In some
cases, this could lead to difficult situations.
However, the psychologists we interviewed state that this
should not be a problem if families openly inform the child
about the oocyte donation.
Remarkably, possible role confusion created by
intrafamilial oocyte donation seems not to be a point of con-
cern in patients. It seems that a low education level is associ-
ated with less concerns regarding role conflicts. In this study,
3/14 patients were in a relationship (see the supplementary
material). One of the partners agreed on participation in this
study. The participant’s view was that their partner’s opinion
should also be explored.
Intra- vs. interfamilial oocyte donation
Most participants agree that conflicts can arise in
intragenerational oocyte donation, when the sister has not ful-
filled her own wish for children before donating oocytes.
Accordingly, sisters who proceeded in the process and were
considering oocyte donation for their galactosemic sister em-
phasize on the need for psychological counseling. Also, par-
ticipants foresee a higher chance of unsolicited interference
with the child’s nurture in intergenerational donation, based
on the family hierarchy, thereby, possibly having more impact
on family relations.
Pressure on the donor and recipient
On one hand, intrafamilial oocyte donation could lead to pres-
sure on the donor. The mothers we interviewed mentioned the
possibility of donating oocytes out of a moral obligation, since
it is a way to help their child. However, according to ethicists,
acting from perceived moral obligation does not mean that
donating oocytes is somehow less voluntary. They state that,
with proper counseling, it is the competent donor’s choice to
judge the proportionality of the treatment, since the respect for
reproductive autonomy applies.
On the other hand, transgenerational pressure can occur, as
one of the ethicists explains:
The notion that your mother has gone through this pro-
cess with hormone stimulation and donation, might give
the daughters a feeling of guilt.
Furthermore, a patient’s future reproductive autonomy can,
thereby, be undermined. However, patients did not express feel-
ing obliged to use the donated oocytes, even when knowing the
effort that has been made. Identity problems in the offspring are
also mentioned as a point of concern by professionals.
Regardless of the possible effects on family relations, par-
ticipants view this technique as something beautiful, if con-
sidered carefully. The perceived greatest advantage of
intrafamilial oocyte donation is genetic closeness, mentioned
by all participants.
Theme 2: which medical aspects should be
considered?
All participants agree that considering the physical condition
of the donor and recipient, including medical background, is
important. Additionally, professionals emphasize consider-
ation of the proportionality of intrafamilial oocyte donation.
This includes the burdens and risks (infertility due to bleeding/
infection) of the IVF treatment on one side and the possible
benefits on the other side. Thereby, a mother’s or sister’s ef-
forts could be in vain:
The galactosemia patient might get pregnant spontane-
ously, not want children, not have a partner, decide to
adopt, find another donor or be so impaired that having
children is not an option.
Theme 3: patient’s cognitive level
Participants agree that cognitive level must be considered
when evaluating the support system for a child.
We do not need perfect parents with a high education; it
is about love, cordiality and providing a safe environ-
ment for the child to grow up in.
However, some professionals wonder whether some of
these patients have the cognitive capacity to oversee the
process of intrafamilial oocyte donation. Another concern
mentioned by professionals is the possibility of assortative
mating. Patients who might have cognitive impairments
are likely to be in a relationship with somebody with a
similar phenotype.
Theme 4: agreements to be made in advance
and organization of counseling
Professionals point out that clear agreement on ownership of
the oocytes should be made. Counseling the oocyte recipient
must be done according to existing guidelines (NVOG 2010,
2016):
A multidisciplinary team should evaluate the whole sys-
tem around a candidate: is there a stable and safe envi-
ronment for the child and how does the social network
look like?
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This multidisciplinary approach should include a consultant in
metabolic diseases, gynecologist, psychologist, social worker,
and others, if needed.
Theme 5: disclosure to the child
Quote from a psychologist:
Secrets cost a lot of energy and the chance of the secret
unintentionally being revealed at some point is high.
The trick is to make it normal for the child; you can
achieve this by informing him/her from a young age,
in an understandable way.
Psychologists state that openly informing the offspring about
the oocyte donation at a young age should be encouraged.
However, there are different views on disclosure amongst oth-
er participants. Most of them would openly inform the off-
spring about the method of their conception. An age when the
child can understand the situation is preferred.
Theme 6: need for follow-up of the offspring?
Recommendations regarding follow-up of the offspring are
missing in the current guidelines. Some professionals think
it is preferable to have a standard check-up occasionally.
Others think you should not medicalize the oocyte donation
and not offer standard care but keep the possibilities for med-
ical and psychological support easily accessible.
Discussion
Our results show that intrafamilial oocyte donation in this
group of patients comes with different considerations that go
beyond the existing recommendations.
Theme 1: intrafamilial oocyte donation and family
relations
Motives and expectations regarding involvement in raising the
child and social roles should be evaluated when counseling
patients and their family members. Donors, recipients, and
partners need counseling together, but also apart from each
other. Furthermore, it is important to evaluate voluntariness
to donate/use the donated oocytes. There are several studies
on intrafamilial oocyte donation in general that evaluated the
effect on family relations and the psychological well-being of
the child. Intragenerational oocyte donation in the general
population does not necessarily have a negative impact on
family relations. Social rather than genetic connection seems
to be of importance in the nature of the relationship with the
child (Jadva et al. 2011; Ilioi et al. 2017). Family relations,
therefore, do not seem to be affected. Furthermore, there is a
gestational and genetic connection between the mother and
the child, suggesting fewer adjustment problems in the off-
spring (Golombok et al. 2013). The possible effect on the
identity of the child has been evaluated in father-to-son sperm
donation. Despite it possibly being emotionally disturbing for
the child and (negatively) affect the child’s identity, it also
allows the child to know its genetic background and be close
to the biological parent (Bredenoord et al. 2012). Studies do
not show differences in psychological adjustment between
children born through gamete donation and naturally con-
ceived children (Golombok et al. 2011, 2013). Although some
participants expressed their concern, data from the literature
so far suggest no psychological problems in the offspring.
After reviewing the literature, we found two reports of
intrafamilial oocyte donation in other genetic disorders. The
first report describes the cryopreservation of a mother’s oo-
cytes for possible future use by her daughter with Turner syn-
drome. The main outcome of this report is the number of
cryopreserved oocytes. Possible limitations of this procedure
are mentioned, including problems with family relations
(Gidoni et al. 2008). The second report describes a sister-to-
sister oocyte donation, where both sisters have intermediate-
size mutations in fragile X mental retardation, with an in-
creased risk for POI (Rybak et al. 2009). This report revealed
that both sisters preferred sibling donation over anonymous
oocyte donation, despite possible problems in family
relations.
Inter- vs. intragenerational oocyte donation
Several differences were mentioned. First, fresh oocyte do-
nation is possible in intragenerational oocyte donation,
whereas there is a need for cryopreservation of the donated
oocytes for a possible future need in intergenerational oo-
cyte donation. In view of the patient’s cognitive level, if
cognitive impairment occurs in patients, this will be fully
clear at time when intragenerational oocyte donation is
considered, as opposed to the intergenerational oocyte do-
nation. This means that the donation and corresponding
emotional stress the donor has gone through could be in
vain. Since a sister can donate fresh oocytes when needed,
the ethical concerns regarding pressure from third parties
to use the oocytes are less likely to play a role. The litera-
ture shows that the majority of patients with POI would
prefer a sister donating oocytes instead of anonymous oo-
cyte donation (Sauer et al. 1988; Lessor et al. 1990; Ethics
Committee, American Society for Reproductive Medicine,
ASRM 2003).
The European Society of Human Reproduction and
Embryology (ESHRE) points out that genetic closeness is a
generally accepted reason for investing time and resources
into treatment (ESHRE Task Force on Ethics and Law et al.
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2011). A mother or sister would be a healthy, easily accessible
source of oocytes, according to professionals. This is impor-
tant because, in general, women who suffer from POI are
required to find an oocyte donor among their own acquain-
tances, as oocyte donors are rare. Also, the process is de-
scribed as less stressful when the donor is known to the recip-
ient (ASRM 2003).
Theme 2: medical aspects to consider
When counseling patients, it is important to mention that the
success rate of this fertility treatment is limited. Furthermore,
to guarantee an appropriate number of oocytes, several at-
tempts could be required. Since there is a higher chance that
the child may be a genetic carrier of galactosemia, screening
the patient’s partner could be considered.
Theme 3: patient’s cognitive level
As mentioned before, cognitive impairment can occur in clas-
sic galactosemia patients. One must bear in mind that possible
cognitive impairments may not be clear at the time intergen-
erational oocyte donation is discussed. Proper and understand-
able information regarding the procedure and possible psy-
chological consequences is required. It is very important to
evaluate the patient’s social network and environment even
more carefully, especially in the long term, so that potential
needs can be acknowledged and necessary measures arranged.
Theme 4: agreements to be made in advance
and organization of counseling
It is important to agree on the ownership of the oocytes ac-
cording to the law in the different countries. European legis-
lation in the field of medically assisted reproduction often
differs between countries and not all European countries have
specific legislation (Busardò et al. 2014). According to Dutch
embryo law (http://wetten.overheid.nl/BWBR0013797/2013-
09-27), the oocytes stay the property of the donor until they
are used by the acceptor. Hereby, mothers could possibly put
terms and conditions upon the donation. Considering the
dependency of the daughter on the mother’s will to donate
oocytes, this could create an unequal relationship and the
oocytes can potentially be used for bribery. Therefore, it
would be preferable for the daughter to have the right to use
the oocytes from her 18th birthday (Balkenende et al. 2017).
Theme 5: disclosure to the child
The results of our study show that early disclosure to the child
is important. This confirms findings in earlier studies. A study
by Golombok et al. has shown that children born through
assisted reproduction, in general, may benefit from disclosure
about the nature of their conception before they enter school
(Golombok et al. 2011). The quality of family relationships
and the psychological well-being of children born through
gamete donation would be better if they are told about the
nature of their conception (Ilioi et al. 2017). Evidence that
keeping the method of conception a secret from the child
would cause harm is minor. However, the chance of uninten-
tional disclosure is expected to be high, especially in
intrafamilial donation, which may be harmful for the child.
Counseling regarding disclosure is, therefore, recommended
Table 1 Considerations for counseling intrafamilial oocyte donation in
galactosemia patients
Family relations
- Evaluate expectations of different parties: donor, recipient, and
partner, regarding involvement in child raising and disclosure.
- Evaluate motives to donate/use oocytes. Ensure that this is done
voluntary and thought through carefully.
- Evaluate if donor has fulfilled own wish to have children.
- Mention that no rights can be derived from intrafamilial oocyte
donation.
Medical impact
- Discuss proportionality of the IVF treatment; possible burdens, risks,
and benefits of the donation process, including the success rate of
IVF treatment.
- Evaluate physical condition of donor and recipient and medical
background. Consider testing donors and patients’ partners as possible
carriers of galactosemia.
Cognitive level
- Evaluation of patients’ social environment and network by a
psychologist/social worker.
- Consider fertile age of the mother; inform the parents of galactosemia
patient as soon as possible but explain that intrafamilial oocyte
donation is an option that her daughter might never (want to/could)
use.
- Provide proper information regarding the procedure and possible
psychological consequences.
- Additional support may be considered.
Agreements to be made in advance and organization of counseling
- Counseling and evaluating of the potential oocyte acceptor by a
multidisciplinary team, according to existing recommendations and
moral fertility treatment contra-indications protocol.
- Consider when to inform the galactosemia patients in case of
intergenerational oocyte donation.
Disclosure to the child
- The ultimate decision about disclosure is made by the parents.
- Counseling regarding disclosure and possibility of unintentionally
revealing the method of conception is recommended.
- If disclosure is preferred, advise families to inform the offspring at a
pre-school age.
Follow-up
- Evaluate social environment and potential role confusion routinely.
This can be done by the involved internist in the annual outpatient
check-up, but it might be preferable to let a psychologist carry out the
follow-up, since there is no experience in this patient population yet.
- Keep in mind that some patients might be lost to follow-up.
- No standard psychological follow-up of the child to be born is
considered necessary.
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(ESHRE 2011). Another argument for disclosure that has been
mentioned is the right for the child to know their biological
origins, for both psychological and medical reasons. This de-
cision should be made by the parents.
Theme 6: need for follow-up
The galactosemia patients are seen in the outpatient clinic
annually. Problems regarding social situation and role confu-
sion could be discussed, if necessary. During the counseling
for this procedure, the option of seeking professional help for
the child, if needed, must be discussed.
This study was conducted in the Netherlands. However, we
do think that the findings in our study are representative of
other European/western countries and could be used as a
guideline when being confronted with questions regarding
intrafamilial oocyte donation. Most studies evaluating the
views on oocyte donation in general derive from the USA or
the UK, and our results are in line with the findings in those
studies (Purewal and van den Akker 2009; ASRM 2012).
Also, the ESHRE (2011) has provided different recommenda-
tions regarding ethical aspects in intrafamilial oocyte donation
that are considered applicable to all European countries.
Conclusion and considerations for counseling
We conclude that intrafamilial oocyte donation in this group
of patients comes with different considerations. The topics to
be considered when discussing intrafamilial oocyte donation
for galactosemia patients are family relations, medical impact,
patient’s cognitive level, agreements to be made in advance
and organization of counseling, disclosure to the child, and
need for follow-up, as summarized in Table 1.
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